Sign in

What researchers published on Liver cirrhosis

40,153 papers, newest first.

Showing 40 of 40,153

  • ReviewThe potential benefit of sodium glucose cotransporter (SGLT)-2 inhibitors in liver cirrhosis: A mini review.Therapeutic advances in gastroenterology
  • ReviewBiomarkers to assess early signs of fibro-inflammatory disease modification following short-term therapeutic intervention in people living with MASLD/MASH: A systematic scoping review.PloS one
  • The Clinical Value of D-D, AT-Ⅲ, NLR, PLT and ALB Measurement in Liver Diseases.Clinical laboratory
  • Predicting Cirrhotic Patients' Transition From Compensated to Decompensated Stage: A Graph-Based Multitask Deep Learning Method.JMIR medical informatics
  • Reply to Letter to the Editor on Beyond Prophylaxis: Antimicrobial Stewardship for Bacterial Infections in Cirrhosis.United European gastroenterology journal
  • Genes That Reliably Differentiate Liver-Fibrosis Stages Identified Using a Novel Integrated Statistical and Machine-Learning Algorithm.Genetic epidemiology
  • Regulatory T-Cell Dynamics During and After Direct Acting Antivirals in Cirrhotic HCV Genotype 4 Patients.Journal of viral hepatitis
  • Development and internal validation of VA-BLED for 1-year esophageal variceal bleeding risk in cirrhosis.PloS one
  • ReviewHepatic metabolic plasticity: From physiological adaptation to energy overload-associated pathological progression and therapeutic targeting.Journal of physiology and biochemistry
  • Integrative transcriptomic and single-nucleus analyses identify microbiota-metabolite-associated immune signatures of fibrosis severity in MASLD.PloS one
  • Two-dimensional speckle-tracking imaging for assessing cardiac dysfunction in liver cirrhosis: correlation with Child-Pugh score.Cardiovascular ultrasound
  • Review[Screening, diagnosis, treatment, and follow-up of hepatitis C virus-related liver disease].Orvosi hetilap
  • Inflammatory bowel disease increases the risk of liver cirrhosis: a retrospective population-based study.Sage open chronic disease
  • PRPF19 drives hepatic stellate cell activation and liver fibrosis via PKM2-mediated glycolytic reprogramming.Nature communications
  • Clinical characteristics and prognostic factors of ascitic fungal infections in patients with cirrhosis.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
  • Anthropometric measurements, nutritional status, and diet quality of cirrhosis patients: Comparison of two etiologies.Hepatology forum
  • Associations of Myosteatosis with Osteoporosis, Vertebral Fractures, and Long-Term Prognosis in Patients with Cirrhosis.Journal of clinical medicine
  • Transcriptome Analysis Reveals the Role of Partial Lymphatic Vessel Ligation in Rats with Cirrhotic Portal Hypertension.Cells
  • Interassay and interlaboratory comparison of von Willebrand factor antigen as a diagnostic and prognostic biomarker in advanced chronic liver disease.Research and practice in thrombosis and haemostasis
  • Metabolomic Differences Between Wild and Cultivated Ophiocordyceps sinensis Identify Source-Associated Metabolites with Predicted Antifibrotic Relevance.International journal of molecular sciences
  • Meta-analysisSilymarin-Based Therapies in Chronic Liver Disease: A Systematic Review of Biochemical, Cardiometabolic, Steatosis, and Fibrosis-Related Outcomes.Nutrients
  • ReviewIntercepting hepatocellular carcinoma in chronic hepatitis B: a structured critical review of Chinese herbal medicine and the immune-fibrotic evidence.Frontiers in immunology
  • Effects of Ketanserin, Reserpine, VEGF, and HGF as Monotherapy and Combination Therapy in Experimental Liver Cirrhosis.Bulletin of experimental biology and medicine
  • Therapeutic Targeting of Hepatic Stellate Cell Inactivation and Collagen Degradation by IC-2 Mitigates Liver Fibrosis.International journal of molecular sciences
  • Effectiveness and Safety of Thalidomide for Gastric Antral Vascular Ectasia-Related Recurrent Gastrointestinal Bleed in Liver Cirrhosis: Prospective Observational Study.Journal of clinical and experimental hepatology
  • Tubastatin A Mitigates Lipotoxicity, Inflammation and Fibrosis Through Downregulation of HDAC6 and Modulation of AMPK-FGF21 Axis in Metabolic Dysfunction-Associated Steatohepatitis.Inflammation
  • Percutaneous cholecystostomy for acute cholecystitis in patients with cirrhosis is associated with healthcare burden and mortality.Medicine
  • Case reportNoncirrhotic Portal Hypertension and Diagnostic Pitfalls in Severe Polycystic Liver Disease: A Case Report.Cureus
  • Impact of Self-Reported Race and Ethnicity in Hospitalized Patients With Acute Kidney Injury and Cirrhosis: Results from the HRS-HARMONY Consortium.Kidney medicine
  • Integrative multi-omic profiling reveals a spatially organized GPNMB⁺ monocyte-derived macrophage-NAMPT axis driving Th17 activation and fibrotic remodeling in cholestatic liver disease.Inflammation research : official journal of the European Histamine Research Society ... [et al.]
  • Impact of Guideline-Based Acute Kidney Injury Care Processes on Outcomes in Hospitalized Patients With Decompensated Cirrhosis.Journal of clinical gastroenterology
  • Dysregulated apoptosis in the spleen from patients with splenomegaly due to cirrhosis.Folia histochemica et cytobiologica
  • MAIT cells exacerbate early liver fibrosis by downsizing the intrahepatic regulatory T cell compartment.Science advances
  • Sivelestat attenuates thrombus burden and NET-associated thrombo-inflammatory responses in experimental non-cirrhotic portal vein thrombosis.Thrombosis research
  • Real world data to improve hepatocellular carcinoma surveillance in cirrhosis.Revista espanola de enfermedades digestivas
  • Validating sarcopenia definitions in Asian patients with cirrhosis: a first and necessary step to characterizing muscle health.Hepatology international
  • Design, Synthesis, and Antifibrotic Evaluation of Silicon-Incorporated Alkyl Hydrazide Analogs of Tubastatin A: HDAC3 Selective Inhibitor for Ameliorating Liver Fibrosis.Journal of medicinal chemistry
  • Magnetic particle imaging reveals microenvironment-driven retention of SPIO-labeled MSCs and enables CXCR3 engineering to enhance antifibrotic therapy.Journal of nanobiotechnology
  • Case reportPleural empyema and perisplenic abscess caused by Clostridioides difficile in a patient with liver cirrhosis and previous C. difficile colitis: a case report.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
  • Efficacy and safety of dabigatran in cirrhosis with chronic portal vein thrombosis: A randomized, placebo-controlled double-blind trial (DAB-PVT).The American journal of gastroenterology